Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Cash from Financing Activities (2023 - 2026)

Alvotech's (ALVO) quarterly Cash from Financing Activities came in at $143.4 million in Q2 2026, up 72.44% on a YoY basis from $83.1 million in Q2 2025, and up 14926.89% quarter-over-quarter from -$967000.0 in Q1 2026.

Analysis

Alvotech (ALVO) Cash from Financing Activities (2023 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Cash from Financing Activities for 4 consecutive years, with $143.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities rose 72.44% year-over-year to $143.4 million; the trailing twelve-month figure through Jun 2026 stood at $335.9 million (up 41.49% YoY), and the FY2025 full-year result was $270.8 million, down 8.9% from the prior year.
  • Cash from Financing Activities improved to $143.4 million in Q2 2026 per ALVO's latest filing, from -$967000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $206.8 million in Q4 2025 and bottomed at -$13.2 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged $60.7 million across 4 years, with a median of $12.5 million in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 4713.06% in 2025, down 108.5% in 2025.
  • Over 4 years, Cash from Financing Activities stood at $20.7 million in 2023, then tumbled by 79.21% to $4.3 million in 2024, then jumped by 4713.06% to $206.8 million in 2025, then slumped by 30.66% to $143.4 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $143.4 million, -$967000.0, and $206.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -1.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -1.24 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -75.18 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 79.36 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -49.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 143.38 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -4.65 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -43.54 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 143.38 Mn
Mar 31, 2026 -967,000.00
Dec 31, 2025 206.77 Mn
Sep 30, 2025 -13.25 Mn
Jun 30, 2025 83.15 Mn
Mar 31, 2025 -5.84 Mn
Dec 31, 2024 4.30 Mn
Sep 30, 2024 155.83 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 133.18 Mn
Dec 31, 2023 20.66 Mn
Jun 30, 2023 -2.73 Mn